TGen-BNI 'one-drop' blood test among new projects funded by Alzheimer's Association and Global Down Syndrome Foundation Posted Monday November 9, 2015 Studying Alzheimer's in people with Down Syndrome may accelerate scientific discovery
TGen will lead international Stand Up To Cancer (SU2C) Dream Team to tackle deadly pancreatic cancer Posted Friday November 6, 2015 Cancer Research UK, Lustgarten Foundation join SU2C in funding $12 million research to improve patient survival; HonorHealth to conduct clinical trials
'Liquid biopsy' promotes precision medicine by tracking patient's cancer Posted Wednesday November 4, 2015 Circulating tumor DNA in blood could inform physicians on best treatments for individual patients
15-year-old daughter races to honor mother's battle with cancer Posted Wednesday October 28, 2015 Ahnna Parkhurst promotes scientific research through Laurie's Fund, Accelerating the Cure for Cancer at TGen
FDA approves new therapy for pancreatic cancer patients Posted Monday October 26, 2015 International clinical trial led by TGen and HonorHealth showed significant overall survival rates
'Mito What?' raises funds and awareness for children with energy draining mitochondrial disease Posted Wednesday October 21, 2015 Oct. 24 event at the Monastery in Mesa supports TGen's Center for Rare Childhood Disorders
Protein found in malaria could help stop cancer Posted Friday October 16, 2015 Malarial protein binds to a sugar molecule found in many types of cancer, enabling anti-cancer drugs to target tumors
Derrick Hall of the Arizona Diamondbacks is honorary chair of TGen's 10th annual stepNout race Nov. 1 Posted Monday October 5, 2015 5K is expected to draw record numbers of participants to the Scottsdale Sports Complex, helping fund TGen's pancreatic cancer research
Federal funding secured for Barrow-TGen advanced technology study of Amyotrophic Lateral Sclerosis Posted Wednesday September 30, 2015 Multi-year study of patients seeks biomarkers that can provide early detection and progression of Lou Gehrig's disease
Research discovery leads to potential diagnostic for assessing breast cancer recurrence Posted Wednesday September 16, 2015 By measuring DNA methylation, TGen researchers might determine which patients are at higher risk for relapse or metastases